Business Context and Reporting Period
This Form 6-K filing by Mizuho Financial Group, Inc. (MHFG) covers the month of March 2026, specifically reporting on the progress of a common stock repurchase program. The report was signed on March 2, 2026, by Takefumi Yonezawa, Senior Managing Corporate Executive / Group CFO.
Key Financial Metrics
The filing focuses exclusively on capital allocation activities regarding share repurchases rather than operational financial performance.
- Shares Repurchased (Feb 2026): 14,640,700 shares
- Cost of Repurchase (Feb 2026): ¥105,024,681,500
- Cumulative Shares Repurchased (Program to date): 39,130,800 shares
- Cumulative Cost (Program to date): ¥249,063,999,400
- Program Cap: Up to 65,000,000 shares or ¥300,000,000,000
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes
As of February 28, 2026, the company has repurchased approximately 60% of the authorized share count (39.1 million of 65 million) and approximately 83% of the authorized capital amount (¥249 billion of ¥300 billion) under the resolution passed on November 14, 2025, and amended on February 2, 2026.
Guidance, Outlook, and Risks
The document contains forward-looking statements regarding estimates and plans but explicitly disclaims any guarantee of future performance. The repurchase program is scheduled to conclude on March 31, 2026. Management directs investors to the "Risk Factors" and "Operating and Financial Review and Prospects" sections of the most recent Form 20-F for details on factors affecting financial condition.
Investor Verification Checklist
- Verify the remaining authorized repurchase amount and share count available under the current program.
- Confirm the final repurchase activity for March 2026 to determine if the program cap was reached.
- Review the most recent Form 20-F for comprehensive financial statements, as this 6-K does not contain operational results.
- Check for any subsequent filings that may supersede the forward-looking statements contained herein.